HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

Switzerland has added treatments for migraine and acute pain to the list of Rx drugs permitted for sale without prescription in pharmacy.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Women's football star and TV personality Alex Scott MBE becomes brand ambassador for Ascension Healthcare's UK pain relief brand FlexiSEQ.

Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.

Vision Healthcare has hired Perrigo's Geert Cools and Joost Hunfeld as CEO and chief growth officer respectively, while at the same time securing the acquisition of Spanish VMS player N2.

Ostensibly taking cues from California and lessons from previous congressional sessions, US lawmakers, NGOs and “forward-thinking cosmetics companies” seek piecemeal cosmetics reform via four federal bills slated for introduction in the coming week.

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

“It is strange,” observed Vera Rogiers, vice chair of the European Commission’s Scientific Committee on Consumer Safety, referring to the problematic intersection of EU chemicals and cosmetics regulations as they pertain to animal testing of cosmetic ingredients.

In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.

Limiting FTC authority to enforcement started after legislation passes rather than all pending complaints as House bill allows could be divisive. But consumer health marketers question number of years before a complaint is filed agency can allege a business used false and misleading advertising under legislation the House passed.

The Los Angeles-based clean beauty pioneer heralded the environmentally friendly relaunch during its June discussion of fiscal 2021 first-quarter results, which included 42% growth in its Skin and Personal Care division.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

FDA debars Jonathan Doyle for five years from importing food in US due to 2020 conviction through a guilty plea on a felony federal charge. Doyle scheduled for release from prison in September 2022; sentences for some co-defendants end sooner, some later.

Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.

FDA states in Federal Register notice that WHO has requested information on whether kratom – mitragynine, 7-hydroxymitragynine – should be added to the United Nations’ schedule of controlled substances.

Vision Healthcare has hired Perrigo's Geert Cools and Joost Hunfeld as CEO and chief growth officer respectively, while at the same time securing the acquisition of Spanish VMS player N2.

In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.

HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Can cannabinoids provide therapeutic benefits to consumers? A new animal study by the UK's TTS Pharma suggests anti-inflammatory properties for CBD, according to the company's director of Medical Affairs, Rob Walton.